Latest filing published 02 Jan 2019 for G1 Therapeutics, Inc., €10k.
Filing timeline
BuySaleInsider track record
Jay Strum: trading record in brief
Jay Strum appears in our data through filings on G1 Therapeutics, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 22 May 2017 to 2 January 2019, the count stands at 10 filings.
On the market, this insider has only sold: 6 sales, €510k in total. The rest of the record consists of 3 option exercises.
The newest entry dates from 2 January 2019: an option exercise of €10k, in G1 Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jay Strum
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 39,485 shares@ US$0.301.9% of flowCommon StockSEC:0001562180-19-000094:0
- 40,333 shares@ US$0.392.6% of flowCommon StockSEC:0001562180-19-000094:1
- 850 shares@ US$0.300.0% of flowCommon StockSEC:0001562180-18-004189:0
- 600 shares@ US$58.405.6% of flowComomon StockSEC:0000899243-18-023647:0
- 3,500 shares@ US$59.1033.1% of flowComomon StockSEC:0000899243-18-023647:1
- 700 shares@ US$60.006.7% of flowComomon StockSEC:0000899243-18-023647:2
- 200 shares@ US$61.002.0% of flowComomon StockSEC:0000899243-18-023647:3
- 500 shares@ US$59.274.8% of flowComomon StockSEC:0000899243-18-023647:4
- 4,500 shares@ US$60.0543.4% of flowComomon StockSEC:0000899243-18-023647:5
- 16,666 sharesCommon StockSEC:0001209191-17-035159:0
10 of 10 declarations